DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer

Journal of Clinical Pathology

Volumn 57, Issue 10, 2004, Pages 1057-1062

  Padmanabhan, V ^b   Callas, P ^a   Philips, G ^a   Trainer, T D ^a,b   Beatty, B G ^b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; MINICHROMOSOME MAINTENANCE PROTEIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN MCM7; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CELL PROLIFERATION; DNA REPLICATION; DYSPLASIA; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA;

ADENOCARCINOMA; AGED; ANALYSIS OF VARIANCE; CELL CYCLE PROTEINS; CELL PROLIFERATION; DNA-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RISK ASSESSMENT; TUMOR MARKERS, BIOLOGICAL;

EID: 4944249496     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.016436     Document Type: Article

References (44)

1. Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
2. Freeman A, Morris LS, Mills AD, et al. Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res 1999;5:2121-32.
3. Hall PA, Levison DA. Review: assessment of cell proliferation in histological material. J Clin Pathol 1990;43:184-92.
4. Goel A, Abou-Ellela A, DeRose PB, et al. The prognostic significance of proliferation in prostate cancer. J Urol Pathol 1996;4:213-23.
5. Scalzo DA, Kallakury BVS, Gaddipati RV, et al. Cell proliferation rate by MIB-1 immunohistochemistry predicts post radiation recurrence of prostate adenocarcinomas. Am J Clin Pathol 1998;109:163-8.
6. Ross JS, Sheehan CE, Dolen EM, et al. Morphologic and molecular prognostic markers in prostate cancer. Adv Anat Pathol 2002;9:115-28.
7. Bravo RR, Frank PA, Blundell H, et al. Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ. Nature 1987;326:515.
8. Nichols AF, Sancar A. Purification of PCNA as a nucleotide excision repair protein. Nucleic Acids Res 1992;20:2441.
9. Shivji KK, Kenny MK, Wood RD. Proliferating cell nuclear antigen is required for DNA excision repair. Cell 1992;69:367.
10. Takasaki Y, Kogure T, Takeuchi K, et al. Reactivity of anti-proliferating cell nuclear antigen (PCNA) murine monoclonal antibodies an human autoantibodies to the PCNA multiprotein complexes involved in cell proliferation. J Immunol 2001;166:4780-7.
11. Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983;31:13-20.
12. Gerdes J, Lemke H, Baisch H, et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-15.
13. Cattoretti G, Becker MH, Key G. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
14. Raymond WA, Leong AS, Bolt JW, et al. Growth fractions in human prostatic carcinoma determined by Ki-67 immunostaining. J Pathol 1988;156:161-7.
15. Gallee MP, Visser-de Jong E, ten Kate FJ, et al. Monoclonal antibody Ki-67 defined growth fraction in benign prostatic hyperplasia and prostatic cancer. J Urol 1989;142:1342-6.
16. Harper ME, Goddard L, Wilson DW, et al. Pathological and clinical associations of Ki-67 defined growth fractions in human prostate carcinoma. Prostate 1992;21:75-84.
17. Visakorpi T. Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma. J Pathol 1992;168:7-13.
18. McLoughlin J, Foster CS, Price P, et al. Evaluation of Ki-67 monoclonal antibody as prognostic indicator for prostatic carcinoma. Br J Urol 1993;72:92-7.
19. Vesalainen SL, Lipponen PK, Talja MT, et al. Proliferating cell nuclear antigen and p53 expression as prognostic factors in T1-2M0 prostatic adenocarcinoma. Int J Cancer 1994;58:303-8.
20. Cher ML, Chew K, Rosenau W, et al. Cell proliferation in prostate adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression. Prostate 1995;26:87-93.
21. Brown C, Sauvangeot BS, Khane H, et al. Cell proliferation and apoptosis in prostate cancer: correlation with pathological stage? Mod Pathol 1996;9:205-9.
22. Coetzee U, Layfield LJ, Hars V, et al. Proliferative index determination in prostatic carcinoma tissue: is there any additional prognostic value greater than that of Gleason score, ploidy and pathological stage? J Urol 1997;157:228-9.
23. Bostwick DG, Grignon DJ, Hammond EH, et al. Prognostic factors in prostate cancer: College of American Pathologists' concensus statement 1999. Arch Pathol Lab Med 2000;124:995-1000.
24. Takisawa H, Mimura S, Kubota Y. Eukaryotic DNA replication: from pre-replication complex to initiation complex. Curr Opin Cell Biol 2000;12:690-6.
25. Maiorano D, Lemaitre JM, Mechali M. Stepwise regulated chromatin assembly of MCM2-7 proteins. J Biol Chem 2000;12:8426-31.
26. Hiraiwa A, Fujita M, Nagasaka T, et al. Immunolocalization of hCDC47 protein in normal and neoplastic human tissues and its relation to growth. Int J Cancer 1997;74:180-4.
27. Williams GH, Romanowski P, Morris LS, et al. Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci U S A 1998;95:14932-7.
28. Hiraiwa A, Fujita M, Adachi A, et al. Specific distribution patterns of hCDC47 expression in cutaneous diseases. J Cutan Pathol 1998;25:285-90.
29. Todorov IT, Werness BA, Wang HQ, et al. HsMCM2/BM28: a novel proliferation marker for human tumors and normal tissues. Lab Invest 1998;78:73-8.
30. Stoeber K, Halsall I, Freeman A, et al. Immunoassay for urothelial cancers that detects DNA replication protein Mcm5 in urine. Lancet 1999;354:1524-5.
31. Meng VM, Grossfeld DG, Williams GH, et al. Minichromosome maintenance protein 2 expression in prostate: characterization and association in outcome after therapy for cancer. Clin Cancer Res 2001;7:2712-18.
32. Stoeber K, Swinn R, Prevost AT, et al. Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments. J Natl Cancer Inst 2002;94:1071-9.
33. Stoeber K, Mills AD, Kubota Y, et al. Cdc6 protein causes premature entry into S phase in a mammalian cell-free system. EMBO J 1998;17:7219-29.
34. Stoeber K, Tlsty TD, Happerfield L, et al. DNA replication licensing and human cell proliferation. J Cell Sci 2001;114:2027-41.
35. Partin AW, Kattan MW, Subong ENP, et al. Combination of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer. JAMA 1997;277:1445-51.
36. Greene F, ed. Cancer staging manual American Joint Committee on Cancer, eds. Philadelphia: Lippincott H, 2002.
37. Chevalier S, Blow JJ. Cell cycle control of replication initiation in eukoryotes. Curr Opin Cell Biol 1996;8:815-21.
38. Bostwick DG. Practical application of predictive factors in prostate cancer. Analyt Quant Cytol Histol 1998;20:323-42.
39. Bostwick DG, Pacelli A, Lopez-Beltran. Molecular biology of prostatic intraepithelial neoplasia. Prostate 1996;29:117-34.
40. Montironi R, Magi Galluzzi C, Diamante L, et al. Prostatic intraepithelial neoplasia: expression and location of proliferating cell nuclear antigen (PCNA) in epithelial, endothelial and stromal nuclei. Virchows Arch 1993;422:185-92.
41. Tamboli P, Amin MB, Schultz DS, et al. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma. Mod Pathol 1996;10:1015-19.
42. Bonkhoff H, Stein U, Remberger K. The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 1994;24:114-18.
43. McNeal JE, Haillot O, Yemoto C. Cell proliferation in dysplasia of the prostate: analysis by PCNA immunostaining. Prostate 1995;27:258-68.
44. De Marzo AM, Nelson WG, Meeker AK, et al. Stem cell features of benign and malignant prostate epithelial cells. J Urol 1998;160:2381-92.